Access cutting-edgecancer immunotherapytreatments in Japan

Japan operates under a highly developed healthcare system regulated by the Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceuticals and Medical Devices Agency (PMDA). This system includes special legal pathways — such as Advanced Medical Care (Senshin Iryo) and conditional approval frameworks — that allow licensed institutions to make newer medical options available under defined safeguards. Our role is to review the patient's intake information and diagnostic history, organize an appropriate referral path, and help connect the case to a licensed Japanese hospital or specialist clinic that is suited to review it further.

Most Japanese specialized clinics do not accept international patients directly. JapanMedAssist bridges this gap by acting as your official administrative coordinator. Here is how we help you successfully secure treatment:

• Overcoming language barriers: Japanese medical facilities communicate exclusively in Japanese. We handle all official correspondence and provide professional document translation services for your records.
• Complex record preparation: clinics require strict, specific health record formats and preliminary screening protocols. We organize your medical history to meet precise Japanese standards.
• Multi-clinic network: treatment protocols vary widely, and clinics frequently decline cases. We leverage established relationships with multiple facilities to find the best match for your specific diagnosis.
• Expedited registration: Japanese oncology centers can be overwhelmed with inquiries. We present your case as a "ready-to-review" medical case, bypassing administrative delays to fast-track your intake.
• On-site interpretation support: to ensure safety and clear communication during your medical appointments, we provide in-person interpretation services at the clinic when necessary.

As clinics offering advanced immunotherapies generally operate on a strict reservation-only system, online consultations are necessary for doctors to evaluate your condition, answer your questions about proposed therapies, and plan the appropriate treatment. We will schedule consultation (conducted via Zoom or Google Meet) at a timeslot that is appropriate for both the patient and the doctor, considering timezone differences.

To accurately assess your condition, doctors prefer to review as much medical information as possible. If available, please provide:

• Recent imaging scans (CT, MRI, PET-CT, X-rays).
• Blood test data and pathology reports.
• A medical summary, treatment history and/or proposed treatment plan from your current oncologist.
• A list of current medications.

Important: We understand, however, that gathering medical records and lab results can take a significant amount of valuable time. If your documents are not ready yet, providing a comprehensive description of your medical history is sufficient for the initial consultation. To expedite your care, we can arrange all necessary imaging, blood tests, and lab work in Japan prior to starting your treatment. Conducting both pre- and post-treatment testing at the same Japanese facilities also ensures a more accurate comparison when evaluating your treatment outcomes.

If a treatment plan is available, review it before the consultation. Write a short list covering your main concerns, current care, timing, and what you hope to understand from the consultation.

Ask about the purpose of the proposed service, available evidence, risks, alternatives, costs, visit requirements, and follow-up responsibilities.

You can upload existing health summaries directly into our secure, encrypted patient workspace. These files are shared safely only with authorized personnel involved in your administrative care coordination. We can also assist with obtaining records from your current care team and securely transferring them to the clinic in Japan.

Documentation guidelines depend on the chosen facility. Submit the available original language versions first, and we will take care of any necessary translation coordination based on their requirements.

Our coordinator first checks the request for administrative completeness. An independent clinic then decides whether it can review the case.

Most requests with complete documentation are processed by us within 1-2 working days, and Japanese clinics typically review cases within the same week. However, timing can vary based on the clinic’s schedule and the complexity of the case. We attempt to find a clinic that can review the case as quickly as possible. A virtual second opinion or consultation is typically scheduled within 1 to 7 business days following clinic acceptance, depending on physician availability.

Japan Medical Assist specializes in non-clinical Japan medical travel support. Our administrative scope includes secure records management, doctor appointment scheduling, professional interpreter coordination, and travel planning for confirmed medical itineraries.

Only licensed clinicians at independent clinics or hospitals provide diagnoses, clinical advice, eligibility decisions, and care recommendations.

• Dendritic Cell (DC) Vaccine: This therapy activates your acquired (adaptive) immunity. It acts like a sniper, using specific cancer markers (antigens) to educate the immune system to recognize, memorize, and specifically attack those cancer cells.
• Activated NK-Cell Therapy: This therapy activates your innate immunity. Natural Killer cells are multiplied and activated in a lab to broadly attack abnormal cells, specifically targeting cancer cells or virus-infected cells that try to hide their markers from the adaptive immune system.

Yes. Because the DC vaccine helps the immune system "memorize" the cancer's profile (much like a standard vaccine memorizes a virus), it is considered highly beneficial for preventing metastasis and relapse. It targets microscopic cancer cells that may remain in the body after surgery.

• Because cancer cells cannot dilate blood vessels properly, they retain heat and reach much higher temperatures than normal cells when exposed to thermal energy.
• At temperatures of 42.5°C and above, cell death occurs; at 43°C, cancer cell viability drops below 1/10,000 within 200 minutes.
• Heating the tumor safely with an 8 MHz high-frequency device locally warms the tissue to 39-41°C, which activates immune cells (like macrophages and NK cells) and improves the uptake of anticancer drugs into the tumor.

• When cancer cells die from targeted treatments (like radiation therapy or specific drugs), they release "danger signals" such as DAMPs.
• These signals naturally activate dendritic cells, triggering a powerful chain reaction that wakes up the immune system to recognize and attack the cancer systemically.

Complete or partial removal (resection) of the tumor is highly preferred over a simple needle biopsy. Surgery helps extend the patient's lifespan and allows for the collection of a sufficient amount of tumor tissue (usually 2 to 5 grams) needed to create the personalized cancer vaccine. If surgery is not possible, a large core needle biopsy can be considered, but it may not provide enough tissue for optimal vaccine production. In cases where no tumor tissue is available, the clinic can use synthesized peptides to create a multivalent vaccine, though this is generally less effective than using the patient's own tumor antigens.

Yes. Preserved (paraffin-embedded) tumor blocks containing dead cancer cells can be utilized. When injected, these dead cells express irritating molecules that provoke and "wake up" the immune system, training it to target the specific biology of your tumor.

We advise booking travel only after your clinic schedule is finalized and you have reviewed all service fees and travel requirements. On-site appointments are typically scheduled within 1 to 3 weeks post-consultation. Once your schedule is confirmed, we can assist with travel arrangements and provide guidance on accommodations near the clinic.

No, these treatments are strictly outpatient, and the clinics generally do not have inpatient facilities. We can recommend or assist with booking accommodations in clinic's vicinity if needed. However, if a patient is traveling from afar or their overall health condition makes daily commuting difficult, the clinic can introduce you to affiliated hospitals where you can stay.

All applicable consultation rates and coordinator fees are disclosed upfront. Because advanced care plans are highly personalized, formal cost estimates are issued only after the clinic reviews the file and provides specific recommendations. Once you receive the clinic's recommendations, we will provide a detailed breakdown of all related fees, including consultation charges, administrative coordination costs, and any anticipated expenses for recommended services. This allows you to make an informed decision about proceeding with the proposed care plan.

Patients may not be eligible if they are taking high-dose steroids, are on strong immunosuppressive therapy, have autoimmune diseases, have a history of organ transplants, or carry viruses that grow within immune cells (such as HIV or HTLV). Additionally, patients whose overall health is too poor (e.g., unable to eat, walk, or travel) might have severely impaired immune systems, making it difficult to achieve the expected treatment outcome.

Clinical follow-up instructions will originate from licensed medical professionals, and the independent Japanese facility providing your care will remain responsible for tracking progress and issuing medical recommendations.

We will stay in touch with you before, during, and after your visit. Please use the secure client portal or contact your coordinator directly for ongoing account management, document updates, or scheduling help. Our team remains available to facilitate follow-up communication with clinics, bookings, or secondary consultations.